Immunology and Microbiology
Gene
100%
Escherichia coli
82%
Prevalence
77%
Biofilm
65%
Pig
64%
Peptoclostridium difficile
54%
Klebsiella pneumoniae
54%
Sample
45%
Minimum Inhibitory Concentration
37%
Antimicrobial Peptides
35%
Animal
33%
Polymerase Chain Reaction
33%
Multidrug Resistance
32%
Human
31%
Antimicrobial Resistance
31%
Multiplex Polymerase Chain Reaction
30%
Bacillus Cereus
27%
Ovary Cell Line
27%
Bacillus Thuringiensis
27%
Probiotic
27%
Piglet
27%
Spore Germination
27%
Dog
27%
Clostridium perfringens
27%
Antimicrobial Activity
27%
Fimbria
27%
Enterococcus faecalis
27%
Antimicrobial Resistance
18%
Colistin
18%
Bacterial Membrane
13%
Microbiome
11%
Proteobacteria
10%
Bacterial Load
10%
Random Amplified Polymorphic DNA
9%
Clostridium
9%
MIC50
9%
Antibacterial Activity
9%
Bacitracin
9%
Gene Cluster
9%
Genome Sequencing
9%
Antibiotic Sensitivity
9%
Operon
9%
Gram-Negative Bacteria
8%
Pseudomonas aeruginosa
7%
Bacillus
7%
Single Nucleotide Polymorphism
6%
Gut Microbiome
6%
Interleukin-6
5%
Absorption
5%
Bone Marrow-Derived Macrophage
5%
Agricultural and Biological Sciences
Cells
54%
Lactobacillus
35%
Pediococcus
35%
Bacteria
31%
Escherichia coli
27%
Enterotoxin
27%
Microbiology
27%
Probiotic
27%
Pig
27%
Clostridium difficile
27%
Boars
27%
Semen
27%
Colostrum
20%
Strain
15%
Antimicrobial Peptides
15%
Lactic Acid Bacteria
11%
Antimicrobial Resistance Genes
11%
Lactose
9%
Escherichia coli
9%
Gentamicin
9%
Proteus mirabilis
9%
Pseudomonas aeruginosa
9%
Assay
7%
Viability
7%
Proteus mirabilis
7%
Semen Extender
7%
Pseudomonas aeruginosa
7%
Antimicrobial Resistance
7%
Nucleotide
6%
Humans
6%
Immunoglobulin A
6%
Pharmacology, Toxicology and Pharmaceutical Science
Ethylenediaminetetraacetic Acid
54%
Combination Therapy
54%
Fat
32%
Dysbiosis
32%
Enterococcus faecium
27%
Anti-Inflammatory Drug
27%
Cytotoxicity Assay
27%
Obesity
27%
Colistin
27%
Carbapenem
27%
Cyproheptadine
27%
Bromhexine
27%
Fluvoxamine
27%
Cytokine
13%
Cytotoxicity
10%
Adjuvant
10%
Palmitic Acid
9%
Pig
7%
Daptomycin
7%
Benzene
5%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
5%
Pathogenicity
5%
Bacillus Cereus
5%
Antiinfective Agent
5%
Inhalation
5%
Respiratory Tract Infection
5%
Pseudomonas Infection
5%